Genetics

Advances in whole-genome sequencing (WGS) are transforming the landscape of neurologic and neurodevelopmental disease research. By uncovering structural variations like copy number variations, transposable elements, and mosaic mutations, WGS is bridging the gap in missing heritability and improving diagnostic yields for conditions like multiple sclerosis, autism, and Alzheimer’s disease. This blog delves into the groundbreaking applications of WGS in clinical neurology, the integration of RNA sequencing for enhanced insights, and the potential of genomic medicine to pave the way for personalized therapies. Explore how WGS is unlocking new frontiers in understanding and managing neurologic disorders.